Downregulated expression of TNF-α, IL-1β, IL-6 and IL-10 proteins indicated that AD-MSCs can also protect the lungs from injury and fibrosis through an anti-inflammatory process, which was consistent with ample experimental evidence in MSC-treated pulmonary fibrosis [28–30]. The gene discussed is IL10; the disease is Alzheimer disease.